2009, Number 6
Next >>
Rev Invest Clin 2009; 61 (6)
La investigación traslacional en cáncer: Reto del Instituto Nacional de Cancerología
Herrera LA, Mohar-Betancourt A
Language: Spanish
References: 4
Page: 451-453
PDF size: 34.80 Kb.
Text Extraction
No abstract
REFERENCES
Chávez-Blanco A, Pérez-Plasencia C, Pérez-Cárdenas E, Carrasco- Legleu C, et al. Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines. Cancer Cell Int 2006; 6: 2.
Candelaria M, Gallardo-Rincón D, Arce C, Cetina L, et al. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Ann Oncol 2007; 18: 1529-38.
Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005; 25: 415-22.
Baselga J, Rosen N. Determinants of RASistance to anti-epidermal growth factor receptor agents. J Clin Oncol 2008; 26: 1582-4.
Full text